1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2014

Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2014" provides data on the Intracerebral Hemorrhage clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Intracerebral Hemorrhage. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Intracerebral Hemorrhage. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Intracerebral Hemorrhage 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Intracerebral Hemorrhage to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Intracerebral Hemorrhage to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Intracerebral Hemorrhage 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Intracerebral Hemorrhage Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Novo A/S 32
Clinical Trial Overview of Novo A/S 32
The Medicines Company 33
Clinical Trial Overview of The Medicines Company 33
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Octapharma AG 35
Clinical Trial Overview of Octapharma AG 35
GlaxoSmithKline plc 36
Clinical Trial Overview of GlaxoSmithKline plc 36
AstraZeneca PLC 37
Clinical Trial Overview of AstraZeneca PLC 37
Clinical Trial Overview of Top Institutes / Government 38
Johns Hopkins University 38
Clinical Trial Overview of Johns Hopkins University 38
Beth Israel Deaconess Medical Center 39
Clinical Trial Overview of Beth Israel Deaconess Medical Center 39
University of Minnesota 40
Clinical Trial Overview of University of Minnesota 40
Sunnybrook Health Sciences Centre 41
Clinical Trial Overview of Sunnybrook Health Sciences Centre 41
Thomas Jefferson University 42
Clinical Trial Overview of Thomas Jefferson University 42
University of California, Los Angeles 43
Clinical Trial Overview of University of California, Los Angeles 43
University of Erlangen-Nurnberg 44
Clinical Trial Overview of University of Erlangen-Nurnberg 44
The George Institute for Global Health 45
Clinical Trial Overview of The George Institute for Global Health 45
University of Oulu 46
Clinical Trial Overview of University of Oulu 46
University of Heidelberg 47
Clinical Trial Overview of University of Heidelberg 47
Five Key Clinical Profiles 48
Appendix 86
Abbreviations 86
Definitions 86
Research Methodology 87
Secondary Research 87
About GlobalData 88
Contact Us 88
Disclaimer 88
Source 88

List of Tables
Intracerebral Hemorrhage Therapeutics, Global, Clinical Trials by Region, 2014* 7
Intracerebral Hemorrhage Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Intracerebral Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Intracerebral Hemorrhage Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Intracerebral Hemorrhage Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Intracerebral Hemorrhage Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Intracerebral Hemorrhage Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Intracerebral Hemorrhage Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Intracerebral Hemorrhage to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Intracerebral Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Intracerebral Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Intracerebral Hemorrhage to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Intracerebral Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Intracerebral Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Intracerebral Hemorrhage Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Intracerebral Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Intracerebral Hemorrhage Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Intracerebral Hemorrhage Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Intracerebral Hemorrhage Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Intracerebral Hemorrhage Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Intracerebral Hemorrhage Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Intracerebral Hemorrhage Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Intracerebral Hemorrhage Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Intracerebral Hemorrhage Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Intracerebral Hemorrhage Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2014* 32
Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medicines Company, 2014* 33
Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 34
Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Octapharma AG, 2014* 35
Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 36
Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 37
Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014* 38
Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2014* 39
Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2014* 40
Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Sunnybrook Health Sciences Centre, 2014* 41
Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2014* 42
Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014* 43
Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Erlangen-Nurnberg, 2014* 44
Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by The George Institute for Global Health, 2014* 45
Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oulu, 2014* 46
Intracerebral Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2014* 47

List of Figures
Intracerebral Hemorrhage Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Intracerebral Hemorrhage Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Intracerebral Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Intracerebral Hemorrhage Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Intracerebral Hemorrhage Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Intracerebral Hemorrhage Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Intracerebral Hemorrhage Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Intracerebral Hemorrhage Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Intracerebral Hemorrhage to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Intracerebral Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Intracerebral Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Intracerebral Hemorrhage to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Intracerebral Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Intracerebral Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Intracerebral Hemorrhage Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Intracerebral Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Intracerebral Hemorrhage Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Intracerebral Hemorrhage Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Intracerebral Hemorrhage Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Intracerebral Hemorrhage Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Intracerebral Hemorrhage Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Intracerebral Hemorrhage Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Intracerebral Hemorrhage Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 87

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.